NUGL EV / EBITDA
Was ist das EV / EBITDA von NUGL?
EV / EBITDA von NUGL, Inc. ist N/A
Was ist die Definition von EV / EBITDA?
EV / EBITDA ist der Unternehmenswert geteilt durch das Einkommen vor Zinsen, Steuern, Abschreibungen und Amortisationen. Es ist ein Maß dafür, wie teuer eine Aktie ist und für Vergleiche zwischen Unternehmen häufiger gültig ist als das Preis-Gewinn-Verhältnis. Er misst den Preis (in Form des Unternehmenswerts), den ein Investor zu Gunsten des Cashflows des Unternehmens (in Form des EBITDA) bezahlt.
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV / EBITDA von Unternehmen in Technology Sektor auf OTC im Vergleich zu NUGL
Was macht NUGL?
NUGL Inc. operates as a vertically integrated medical cannabis company. It operates cultivation facility, processing facility, three retail dispensaries, conditional licenses, and supplies and exports medical cannabis primarily in the Caribbean, Australia, and South America. The company was founded in 2018 and is based in Kingston, Jamaica.
Unternehmen mit ev / ebitda ähnlich NUGL
- Sino Vision Worldwide hat EV / EBITDA von N/A
- Respiri hat EV / EBITDA von N/A
- Fuse Cobalt Inc hat EV / EBITDA von N/A
- CCT Fortis hat EV / EBITDA von N/A
- XPhyto Therapeutics hat EV / EBITDA von N/A
- Vital Mobile hat EV / EBITDA von N/A
- NUGL hat EV / EBITDA von N/A
- Australian Bauxite hat EV / EBITDA von N/A
- Evershine hat EV / EBITDA von N/A
- StrikeForce Technologies hat EV / EBITDA von N/A
- Arcutis Biotherapeutics Inc hat EV / EBITDA von N/A
- Golden Dawn Minerals hat EV / EBITDA von N/A
- Austral Gold hat EV / EBITDA von N/A